Marley Kayden says "to say expectations are low is fair" for UPS Inc. (UPS), however, you may not want to count the stock out. While UPS faces tariff pricing pressures and a cut to its dividend, Marley points the company's aggressive cost cutting measures as a way to balance losses.

BTM rides a 228% share surge as it scales kiosk expansion, crypto deals and Bitcoin holdings to fuel growth.

Carnival rides on strong bookings, margin gains and earnings momentum, while Norwegian Cruise trails with softer growth and cost pressures.

Carter's posted positive comp sales and unit growth, signaling market share gains despite a declining US baby population. Profitability sharply deteriorated, with adjusted operating income down 75% and GAAP profits nearly breakeven due to price cuts, off-price sales, and rising SG&A. Upcoming tariffs pose major cost headwinds, and planned price increases may not be fully absorbed by consumers, risking further volume and profit declines.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Flywire Corporation (“Flywire” or the “Company”) (NASDAQ: FLYW) between February 28 , 202 4 and February 25 , 202 5, inclusive. For more information, submit a form at Flywire Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.

LOS ANGELES , July 28, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws. Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The Las Vegas Sphere will soon screen 1939's "The Wizard of Oz" in the immersive event venue's first film experience. Engineers used AI "outpainting" to expand the original film frames to fit the immersive space, CBS Sunday Morning reported.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lockheed Martin Corporation (“Lockheed” or the “Company”) (NYSE: LMT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Tesla has signed a $16.5 billion deal to get its next-generation chips from Samsung.

Let's look at five biotech and drug companies, MRK, AZN, BMY, ABBV and MRNA, slated to release their second-quarter 2025 results this week.

NAVI is set to report Q2 results, with revenues likely to increase. However, earnings are likely to have declined amid weaker loan volumes and income.

SAN FRANCISCO , July 28, 2025 /PRNewswire/ -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution ("IDR") vendor HaloMD. Blue Orca's accusations have prompted national shareholders rights firm Hagens Berman to open an investigation into whether Nutex may have misled investors about the propriety of steps taken in response to recent federal protections for consumers and urges Nutex investors who suffered substantial losses to submit your losses now.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK--(BUSINESS WIRE)--Burberry Beauty unveils Burberry Goddess Parfum – a celebration of the strength, confidence and kindness within, and the latest chapter in the Burberry Goddess fragrance story. Created by renowned perfumer Amandine Clerc-Marie, the new Parfum introduces unexpected twists. ‘I amplified the power and sensuality of the three signature vanilla accords at the heart of the Goddess fragrance,' says Clerc-Marie, who also included a surprising soft suede accent at the base – e.

Biogen's Q2 results may show MS drug declines partially offset by gains from newer drugs.

The solid-state battery startup QuantumScape QS has seen its stock more than double over the past month, fueled by a mix of technical breakthroughs and renewed excitement around its deepening partnership with German auto giant Volkswagen VWAGY. While QuantumScape's story and potential might be compelling, its recent surge raises questions about whether the stock has run too far, too fast.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

I initiate Neogen Corporation with a Buy rating and a fair value of $6.67, citing strategic focus on core food and animal safety markets. Recent divestitures and the 3M Food Safety merger sharpen Neogen's niche positioning and support long-term growth potential. New leadership, including incoming CEO Mike Nassif, is expected to drive integration, margin improvement, and cash flow priorities.